Fulminant hepatitis and late onset hepatic failure in Japan

Hepatology Research

Volumn 38, Issue 7, 2008, Pages 646-657

  Fujiwara, Kenji ^a,b   Mochida, Satoshi ^a   Matsui, Atsushi ^a   Nakayama, Nobuaki ^a   Nagoshi, Sumiko ^a   Toda, Gotaro ^c,d  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

^c Senpo Tokyo Takanawa Hospital   (Japan)

^d Japan Ministry of Health Labour and Welfare   (Japan)

Author keywords

Artificial liver support; Fulminant hepatitis; Hepatic encephalopathy; Liver transplantation; LOHF

Indexed keywords

ANTICOAGULANT AGENT; BRANCHED CHAIN AMINO ACID; CYCLOSPORIN A; GABEXATE MESILATE; GLUCAGON; GLUCOCORTICOID; INSULIN; INTERFERON; LAMIVUDINE; METHYLPREDNISOLONE; NAFAMSTAT MESILATE; PROSTAGLANDIN E1; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HEALTH SURVEY; HEMODIAFILTRATION; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPAN; LATE ONSET LIVER FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TOXIC HEPATITIS; VIRUS HEPATITIS;

EID: 44649132697     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00322.x     Document Type: Article

References (16)

1. The Proceedings of the 12 th Inuyama Symposium. Hepatitis Type A and Fulminant Hepatitis. Tokyo: Chugai Igaku-Sha, 1982. (In Japanese.)
2. Mochida S, Fujiwara K. Symposium on clinical aspects in hepatitis virus infection. Recent advances in acute and fulminant hepatitis in Japan. Intern Med 2001; 40: 175-7.
3. Mori M, Itanai F, Washio S et al. Estimated number of patients with intractable liver diseases in Japan based on nationwide epidemiology surveillance. Annual Report of Epidemiology Research for Intractable Diseases in Japan, the Ministry of Health, Welfare and Labor (2005). 2006; 39-42. (In Japanese.)
4. Suzuki K, Takikawa Y, Endo T. Prospective study to clarify the prognosis of patients with fulminant hepatitis and acute hepatitis severe type. Annual Report of Intractable Liver Diseases Study Group of Japan, the Ministry of Health, Welfare and Labor (2001). 2002; 87-96. (In Japanese.)
5. Sato S, Suzuki K, Takikawa Y et al., Japanese National Study Group of Fulminant Hepatitis. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: An analysis of 1309 cases in a 15-year national survey. Hepatol Res 2004, 2002; 30: 155-61.
6. Matsunami H, Makuuchi M, Kawasaki S et al. Living-related liver transplantation in fulminant hepatic failure. Lancet 1992; 340: 1411-12.
7. Ng HJ, Lim LC. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: Case report. Ann Hematol 2001; 80: 549-52.
8. Fujiwara K, Mochida S, Matsui A. Fulminant hepatitis and LOHF in Japan. Annual Report of Intractable Liver Diseases Study Group of Japan, the Ministry of Health, Welfare and Labor (2001). 2002; 62-77. (In Japanese.)
9. Takahashi K, Iwata K, Watanabe N et al. Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan. Virology 2001; 287: 9-12.
10. Takahashi K, Kang JH, Ohnishi S etal. Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. J Infect Dis 2002; 185: 1342-5.
11. Mizuo H, Suzuki K, Takikawa Y et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol 2002; 40: 3209-18.
12. Fujiwara K, Ogata I, Ohta Y et al. Intravascular coagulation in acute liver failure in rats and its treatment of antithrombin III. Gut 1998; 29: 1103-8.
13. Mochida S, Ogata I, Hirata K etal. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990; 99: 771-7.
14. Yoshiba M, Yamada M, Inoue K et al. Possible prevention of fulminant hepatic failure in four children with acute severe hepatitis. J Gastroenterol 2004; 39: 399-400.
15. Masaki N, Ohta Y, Shirataki H et al. Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury. Gastroenterology 1992; 102: 572-6.
16. Yamagishi Y, Saito H, Tada S etal. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol 2005; 20: 1843-9.